Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis: Victoria, British Columbia Thursday, November 14, 2024, ...
The data show: One patient achieved complete histological remission, defined by the presence of fewer than six eosinophils per high-powered field on esophageal biopsy. Straumann Dysphagia Index, a ...
Esophageal Catheters Market. The global esophageal catheters market is poised for significant expansion, with a projected market value of USD 2.2 billion in 2022, and a robust com ...
The swallowing reflex, which is mediated by the swallowing center in the medulla (the lower part of the brain stem), causes the food to be further pushed back into the pharynx and the esophagus (food ...
Eosinophilic esophagitis is a clinicopathological disease characterized by a wide variety of GERD-like symptoms, dysphagia and vomiting that occur in conjunction with dense esophageal eosinophilia ...